Protease-activated receptor-2 (PAR-2): Structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes

被引:48
|
作者
Maryanoff, BE [1 ]
Santulli, RJ [1 ]
McComsey, DF [1 ]
Hoekstra, WJ [1 ]
Hoey, K [1 ]
Smith, CE [1 ]
Addo, M [1 ]
Darrow, AL [1 ]
Andrade-Gordon, P [1 ]
机构
[1] RW Johnson Pharmaceut Res Inst, Drug Discovery, Spring House, PA 19477 USA
关键词
protease-activated receptor; agonist peptides; intracellular calcium; structure-activity; tethered-ligand receptor; transfected cells;
D O I
10.1006/abbi.2000.2207
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protease-activated receptor-a (PAR-S) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (-/-) cell line transfected with either human PAR-8 or PAR-1. A "directed" library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-8 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-S. The most potent agonist peptides (EC50 = 2-4 muM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05-0.35 muM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 muM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Re and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists. (C) 2001 Academic Press.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 50 条
  • [21] Protease-activated Receptor-2 (PAR2) in Human Periodontitis
    Holzhausen, M.
    Cortelli, J. R.
    Araujo da Silva, V.
    Nobre Franco, G. C.
    Cavalca Cortelli, S.
    Vergnolle, N.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (09) : 948 - 953
  • [22] Protease-activated receptor-2 (PAR2) in cardiovascular system
    Bucci, M
    Roviezzo, F
    Cirino, G
    VASCULAR PHARMACOLOGY, 2005, 43 (04) : 247 - 253
  • [23] Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo
    Sobey, CG
    Cocks, TM
    STROKE, 1998, 29 (07) : 1439 - 1444
  • [24] THE CRITICAL ROLES OF GINGIPAINS IN CELL MIGRATION AND INFLAMMATORY RESPONSES OF MICROGLIA THROUGH ACTIVATION OF PROTEASE-ACTIVATED RECEPTOR-2 (PAR-2)
    Liu, Yicong
    Wu, Zhou
    Kadawaki, Tomoko
    Nakanishi, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S148 - S148
  • [25] Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo
    Cocks, TM
    Sobey, CG
    FASEB JOURNAL, 1998, 12 (05): : A953 - A953
  • [26] Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries
    Moffatt, JD
    Cocks, TM
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) : 591 - 594
  • [27] Roles of protease-activated receptor-2 (PAR-2), a G protein-coupled receptor, in modulation of exocrine gland functions
    Nishikawa, Hiroyuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 (07): : 481 - 488
  • [28] A potent peptide-mimetic antagonist for the tethered-ligand receptor protease-activated receptor-1
    Derian, CK
    Addo, MF
    Darrow, AL
    Eckardt, AJ
    Hoekstra, WJ
    Maryanoff, BE
    McComsey, DF
    Oksenberg, D
    Reynolds, E
    Santulli, RJ
    Scarborough, RM
    White, KB
    Zhang, HC
    Andrade-Gordon, P
    THROMBOSIS AND HAEMOSTASIS, 1999, : 483 - 483
  • [29] Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion
    Kawao, N
    Sakaguchi, Y
    Tagome, A
    Kuroda, R
    Nishida, S
    Irimajiri, K
    Nishikawa, H
    Kawai, K
    Hollenberg, MD
    Kawabata, A
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (05) : 1292 - 1296
  • [30] An Exogenous Glycosidase, Xylanase, Induces Human Eosinophil Degranulation Through Protease-Activated Receptor-2 (PAR-2).
    Matsuwaki, Y.
    Lawrence, C. B.
    Kita, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S270 - S270